Literature DB >> 7665161

Structural organization and chromosomal assignment of the human prostacyclin receptor gene.

Y Ogawa1, I Tanaka, M Inoue, Y Yoshitake, N Isse, O Nakagawa, T Usui, H Itoh, T Yoshimasa, S Narumiya.   

Abstract

Prostacyclin receptor is a member of the prostanoid receptor family in the G protein-coupled receptor superfamily with seven transmembrane domains. We report here the isolation and structural organization of the human prostacyclin receptor gene. Southern blot analysis demonstrated a single copy of the human prostacyclin receptor gene in the human genome. The human prostacyclin receptor gene spanned approximately 7.0 kb and was composed of three exons separated by two introns. The first intron occurred in the 5'-untranslated region, 13 bp upstream to the ATG start codon. The second intron was located at the end of the sixth transmembrane domain, thereby separating it from the downstream coding region and the 3'-untranslated region. By primer extension analysis, the transcription initiation sites were mapped 870-872 bp upstream to the ATG start codon. The 1.2-kb human prostacyclin receptor 5'-flanking region lacked conventional TATA and CCAAT boxes, but it contained several cis-acting regulatory elements including an inverted CCAAT box (Y box) and two copies of SP-1 binding sites. Using human-rodent somatic hybrid cell DNA, the human prostacyclin receptor gene was assigned to human chromosome 19. The present study helps establish the genetic basis for prostacyclin receptor research and provides further insight into the molecular mechanisms underlying the prostanoid receptor family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665161     DOI: 10.1006/geno.1995.1016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction.

Authors:  Jeremiah Stitham; Eric Arehart; Larkin Elderon; Scott R Gleim; Karen Douville; Zsolt Kasza; Kristina Fetalvero; Todd MacKenzie; John Robb; Kathleen A Martin; John Hwa
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  Characterization of the gene for the mouse prostaglandin E receptor subtype EP2: tissue-specific initiation of transcription in the macrophage and the uterus.

Authors:  M Katsuyama; Y Sugimoto; K Okano; E Segi; R Ikegami; M Negishi; A Ichikawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR).

Authors:  Jeremiah Stitham; Eric J Arehart; Scott Gleim; Karen Douville; Todd MacKenzie; John Hwa
Journal:  Gene       Date:  2007-04-01       Impact factor: 3.688

Review 4.  Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Authors:  Scott Gleim; Zsolt Kasza; Kathleen Martin; John Hwa
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

5.  Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.

Authors:  Eric Arehart; Jeremiah Stitham; Folkert W Asselbergs; Karen Douville; Todd MacKenzie; Kristina M Fetalvero; Scott Gleim; Zsolt Kasza; Yamini Rao; Laurie Martel; Sharon Segel; John Robb; Aaron Kaplan; Michael Simons; Richard J Powell; Jason H Moore; Eric B Rimm; Kathleen A Martin; John Hwa
Journal:  Circ Res       Date:  2008-03-06       Impact factor: 17.367

6.  A Report of a Novel Mutation in Human Prostacyclin Receptor Gene in Patients Affected with Migraine.

Authors:  Majid Kheirollahi; Mohammad Reza Pourreza; Fariborz Khorvash; Mohammad Kazemi; Gilda Amini
Journal:  Iran J Psychiatry       Date:  2017-07

Review 7.  G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Authors:  Zeinab Vahidinia; Mohammad Taghi Joghataei; Cordian Beyer; Mohammad Karimian; Abolfazl Azami Tameh
Journal:  Mol Neurobiol       Date:  2021-06-12       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.